129 related articles for article (PubMed ID: 7756686)
1. Effects of protein kinase C inhibitor, staurosporine derivative CGP 41 251, on cell cycle, DNA synthesis and drug uptake in neoplastic cell lines.
Sedlak J; Hunakova L; Duraj J; Chorvath B; Novotny L
Anticancer Drugs; 1995 Feb; 6(1):70-6. PubMed ID: 7756686
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of 1-(beta-D-arabinofuranosyl)cytosine (AraC)-induced apoptosis in the multidrug resistant human promyelocytic leukemia cell lines with protein kinase inhibitors.
Hunáková L; Suliková M; Duraj J; Sedlák J; Chorváth B
Neoplasma; 1996; 43(5):291-5. PubMed ID: 8996546
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase inhibitor-induced alterations of drug uptake, cell cycle and surface antigen expression in human multidrug-resistant (Pgp and MRP) promyelocytic leukemia HL-60 cells.
Sedlák J; Hunáková L; Suliková M; Chorváth B
Leuk Res; 1997 May; 21(5):449-58. PubMed ID: 9225074
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine.
Courage C; Bradder SM; Jones T; Schultze-Mosgau MH; Gescher A
Int J Cancer; 1997 Nov; 73(5):763-8. PubMed ID: 9398059
[TBL] [Abstract][Full Text] [Related]
5. The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance.
Utz I; Hofer S; Regenass U; Hilbe W; Thaler J; Grunicke H; Hofmann J
Int J Cancer; 1994 Apr; 57(1):104-10. PubMed ID: 7908658
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process.
Segal-Bendirdjian E; Jacquemin-Sablon A
Exp Cell Res; 1995 May; 218(1):201-12. PubMed ID: 7537690
[TBL] [Abstract][Full Text] [Related]
7. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
[TBL] [Abstract][Full Text] [Related]
8. Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to apoptosis induced by 7-hydroxystaurosporine.
Somerville L; Cory JG
Int J Oncol; 2000 Oct; 17(4):797-803. PubMed ID: 10995894
[TBL] [Abstract][Full Text] [Related]
9. Effects of the new selective protein kinase C inhibitor 4'-N-benzoyl staurosporine on cell cycle distribution and growth inhibition in human small cell lung cancer cells.
Ikegami Y; Yano S; Nakao K
Arzneimittelforschung; 1996 Feb; 46(2):201-4. PubMed ID: 8720314
[TBL] [Abstract][Full Text] [Related]
10. [Cisplatin resistance in a murine leukemia cell line associated with defect of apoptosis].
Segal-Bendirdjian E; Jacquemin-Sablon A
Bull Cancer; 1996 May; 83(5):371-8. PubMed ID: 8680089
[TBL] [Abstract][Full Text] [Related]
11. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitization of cancer cells by the staurosporine derivative CGP 41251 in association with decreased P-glycoprotein phosphorylation.
Beltran PJ; Fan D; Fidler IJ; O'Brian CA
Biochem Pharmacol; 1997 Jan; 53(2):245-7. PubMed ID: 9037258
[TBL] [Abstract][Full Text] [Related]
13. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
Grant S; Turner AJ; Bartimole TM; Nelms PA; Joe VC; Jarvis WD
Oncol Res; 1994; 6(2):87-99. PubMed ID: 7949469
[TBL] [Abstract][Full Text] [Related]
14. A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity.
Meyer T; Regenass U; Fabbro D; Alteri E; Rösel J; Müller M; Caravatti G; Matter A
Int J Cancer; 1989 May; 43(5):851-6. PubMed ID: 2714889
[TBL] [Abstract][Full Text] [Related]
15. The antitumor activity of doxorubicin against drug-resistant murine carcinoma is enhanced by oral administration of a synthetic staurosporine analogue, CGP 41251.
Killion JJ; Beltran P; O'Brian CA; Yoon SS; Fan D; Wilson MR; Fidler IJ
Oncol Res; 1995; 7(9):453-9. PubMed ID: 8835289
[TBL] [Abstract][Full Text] [Related]
16. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.
Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S
Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780
[TBL] [Abstract][Full Text] [Related]
17. UCN-01 and camptothecin induce DNA double-strand breaks in p53 mutant tumor cells, but not in normal or p53 negative epithelial cells.
Jones CB; Clements MK; Redkar A; Daoud SS
Int J Oncol; 2000 Nov; 17(5):1043-51. PubMed ID: 11029511
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter.
Begemann M; Kashimawo SA; Choi YA; Kim S; Christiansen KM; Duigou G; Mueller M; Schieren I; Ghosh S; Fabbro D; Lampen NM; Heitjan DF; Schiff PB; Bruce JN; Weinstein IB
Clin Cancer Res; 1996 Jun; 2(6):1017-30. PubMed ID: 9816263
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C.
Akinaga S; Nomura K; Gomi K; Okabe M
Cancer Chemother Pharmacol; 1993; 32(3):183-9. PubMed ID: 8500222
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of synergism of drugs cis-diamminedichloroplatinum (II) and arabinosylcytosine on the level of chemical interaction with DNA and on the growth of mouse leukemia.
Rauko P; Novotný L; Reichelová V; Balázová E
Gen Pharmacol; 1991; 22(5):805-10. PubMed ID: 1761184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]